Day One

Reviewing the organisation of the US Food and Drug Administration (FDA) and how this may impact future regulation

Examining drug development regulations in the US and implications for the industry

Evaluation of review options and obtaining information from the FDA

Analysing the Investigational New Drug Application (IND) and defining the regulatory requirements

Maintaining active INDs successfully

Identifying recent changes and other IND/NDA topics